List/Grid

Tasteology & Co. Announces Strategic Expansion and Opens Doors to New Clean-Label CPG Partnerships for Q4 2025 Launches

MIAMI, July 31, 2025 (GLOBE NEWSWIRE) — Tasteology & Co., a premium food science lab and formulation studio established in 2017, today announced its strategic expansion and the opening of limited client onboarding for clean–label CPG brands... More >>

Ambiq Divulga Preço da Oferta Pública Inicial Ampliada

AUSTIN, Texas, July 30, 2025 (GLOBE NEWSWIRE) — A Ambiq Micro, Inc. (“Ambiq”), líder em tecnologia de soluções de semicondutores de potência ultrabaixa para Edge AI, divulgou hoje o preço da... More >>

Ambiq gibt Preisgestaltung für aufgestockten Börsengang bekannt

AUSTIN, Texas, July 30, 2025 (GLOBE NEWSWIRE) — Ambiq Micro, Inc. („Ambiq“), ein Technologieführer im Bereich extrem stromsparender Halbleiterlösungen für Edge–KI, hat heute die Preisgestaltung für... More >>

Ambiq annonce le prix d’émission de son action dans le cadre de son introduction en bourse élargie

AUSTIN, Texas, 30 juill. 2025 (GLOBE NEWSWIRE) — Ambiq Micro, Inc. (« Ambiq »), leader technologique des solutions de semi–conducteurs ultra–basse consommation pour l’IA de pointe, a... More >>

Emaar The Economic City & Al Tahaluf Sign Deal to Deliver New Residential Projects in KAEC’s Al Murooj

KING ABDULLAH ECONOMIC CITY (KAEC), Saudia Arabia, July 30, 2025 (GLOBE NEWSWIRE) — Emaar, The Economic City (EEC), the master developer of King Abdullah Economic City (KAEC), has signed an agreement with Al Tahaluf, a Saudi–American joint... More >>

DebitMyData Closes Oversubscribed Seed Round- Launches $1B Human Energy Grid Global Expansion


DebitMyData™ Logo

FORT LAUDERDALE, Fla., July 30, 2025 (GLOBE NEWSWIRE) — DebitMyData™, Inc.—the powerhouse has closed a seed round at more than twice its... More >>

Marital Rape: Confronting Religious Misinterpretations, Social Stigma, Despite Legal Clarity

From beautiful bride, to victim of marital rape, this is the story of Shanti, a...<a href= More >>

Dr. Falk Pharma und Allianthera (Suzhou) Biopharmaceuticals gehen strategische Partnerschaft für die Entwicklung eines neuartigen AhR-Agonisten ein

Freiburg (Deutschland), Suzhou (China) und Boston (USA), 30. Juli 2025: 

Dr. Falk Pharma GmbH und Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. geben strategische Partnerschaft für die Entwicklung eines neuartigen AhR–Agonisten... More >>